Sameer Bansilal MD, MS

The Kings of College Basketball 〽️

#GoBlue 〽️〽️〽️〽️〽️〽️〽️🏀🏀🏀🏀🏀🏆🏆🏆🏆🏆🏆

NATIONAL CHAMPIONS!

Go Blue 〽️!!

@Alnylam is joining forces with the @American_Heart for improved care delivery in #ATTRCM! #Alnylamproud

@cathaypacific Your direct messaging is not user friendly

@sameerbansilal Please send us a direct message if you need any further assistance with your booking. Thank you for your understanding.

@cathaypacific - you cancelled our direct flight to JFK from HK yesterday for weather reasons.Offered us a one stop flight back 3 days later. I’ve arranged my own travel back- now I see our direct flight scheduled to depart at the gate besides our current gate. Disappointing .

@cathaypacific You have that plane leaving today at 10 am but you offered me a one stop flight 3 days later. Why?

@sameerbansilal Hi Sameer Bansilal MD, We’re very sorry for the frustration caused. The flight was impacted by adverse weather conditions and we understand how disappointing this must have been.

Congratulations, Hoosier Nation and Coach Cignetti!! What a game! What a season!! Fernando Mendoza- is there anything this guy can't do?

It is this time of the year to apply for our amyloidosis fellowship. Eligible candidates are BC/BE IM/Cardiology or other subspecialties app.smartsheet.com/b/form/e7243ff… Thanks to @Amyloidosis_ARC for their continued support #CardioTwitter

Join us next week CVCT - Cardiovascular Clinical Trialists for exciting sessions covering amyloid, HCM, genetic cardiomyopathies and gene therapies globalcvctforum.com/scientific-pro… #cardiotwitter

Congratulations, A team!! @mike_sharma2 @Ash_Shoamanesh @SaraHegabMD @MariaBorentain @sfm_tri

@sameerbansilal @Ron_Witteles @sameerbansilal Hello, you can read it here: threadreaderapp.com/thread/1988095… Talk to you soon. 🤖

@Ron_Witteles @threadreaderapp unroll

(14/14) I leave you with my take-home slide from #AHA25. There are some reasons for optimism with coramitug and the ATTR antibody depleters – but this is hardly an unequivocal win or the “holy grail”. Let’s see what we learn with time – and more data.

(1/14) 🚨I had the privilege of providing commentary on the Phase 2 #coramitug trial at #AHA25. The headline was that patients who received high-dose (60 mg/kg) coramitug had significant reductions in NT-proBNP at 1 year compared with placebo. So it’s an unequivocal win, right? The full story is a bit more complicated…🤔

At @HFSA we shared new data evaluating the impact of #RNAi on gastrointestinal events – a common and challenging manifestation for patients living with #amyloidosis with #cardiomyopathy (ATTR-CM). Read our press release: bit.ly/3We6gXm

Transthyretin cardiac amyloidosis is the leading cause of HF in older Black patients, particularly for men, and screening with nuclear imaging should be more frequent for this population, based on findings from the SCAN-MP study. tctmd.com/news/transthyr…

Today at #ESCcongress: #HFC member Dr. Ankeet Bhatt presents the breakthrough results of the KP-VACCINATE Megatrial — a landmark study in vaccination and cardiovascular prevention. Congratulations @ankeetbhatt 👏🏼👏🏼 #ESC2025 #WCCardio